Keep up-to-date on the latest psoriatic arthritis (PsA) research with our brief research summaries.
PsA May Put Liver at Risk
People with PsA may have an increased risk of liver disease, according to a new study that followed more than a million people for an average of 6 years. People with psoriasis were 37% more likely to develop liver disease than those without inflammatory diseases, the study found. Those with PsA were 38% more likely to have liver disorders. Taking methotrexate further increased their risk.
SOURCE: Journal of Investigative Dermatology, April 2018
Continue reading PsA Research Briefs: Comorbidities
People with ankylosing spondylitis or psoriatic arthritis who take cholesterol-lowering drugs called statins seem to live longer than people who don’t take them, according to researchers at Massachusetts General Hospital in Boston. They presented their findings recently at the American College of Rheumatology’s 2016 Annual Meeting.
In a previous study, Massachusetts General researchers found that people with rheumatoid arthritis (RA) who took statins lived longer, and they wanted to know if the drugs would offer a similar benefit to patients with other types of inflammatory arthritis, such as ankylosing spondylitis (AS) and psoriatic arthritis (PsA). AS mainly affects the spine, especially the sacroiliac joint where the spine meets the pelvis. PsA affects joints as well as skin.
Continue reading Statins May Cut Death Risk in Those with Psoriatic Arthritis & Ankylosing Spondylitis